Our findings have implications for other cancer types that harbor SMARCB1 deficiencies, including epithelioid sarcomas, renal medullary carcinoma, epithelioid malignant peripheral nerve sheath tumors, and extraskeletal myxoid chondrosarcomas (Margol and Judkins, 2014). This evidence concerns the gene SMARCB1 and Epithelioid Malignant Peripheral Nerve Sheath Tumor.